What’s funding like in the Pet Tech market right now?

All funding deals in the Pet Tech market over the last 24 months

Below is the table listing all the deals. You can find our methodology at the end of this page.

If you want a deeper understanding of the market and its current dynamics, get our report covering the Pet Tech Market.

Is Pet Tech funding actually healthier right now?

Pet Tech funding is easier to enter today, but much harder to scale through.

We counted 17 deals in the latest 12-month period, down from 19 a year earlier, while disclosed capital fell from at least $98.38 million to $66.27 million. The median known round also dropped by one-third, from $2.55 million to $1.69 million.

Yet the entry point improved sharply. Nine companies received their first financing, compared with six in the previous period. First financings now represent 52.9% of deals, up from 31.6%.

So Pet Tech is still producing new funded startups. The weakness comes later, where large checks are going to a much smaller group of companies and capital is arriving less consistently through the year.

There is one important caveat when we read the dollar totals. Five of the 17 current rounds have no precise disclosed size, compared with only one of 19 previously. Several of those undisclosed deals are Chinese financings described only as "tens of millions of RMB", so $66.27 million is a floor rather than the full amount invested.

Pet Tech funding metric	Latest 12M	Previous 12M	Change
Deals	17	19	-10.5%
Unique funded companies	17	18	-5.6%
Disclosed capital	≥$66.27M	≥$98.38M	-32.6%
Median disclosed round	$1.69M	$2.55M	-33.6%
Average disclosed round	$5.52M	$5.47M	+1.0%
First-financing share	52.9%	31.6%	+21.4 pp
Follow-on share	47.1%	68.4%	-21.4 pp
Precise round-size coverage	70.6%	94.7%	-24.1 pp

Did Pet Tech funding really fall by one-third?

Pet Tech disclosed funding fell 32.6%, although the real contraction is probably smaller than that headline suggests.

The disclosure problem explains part of the gap. Almost 30% of current deals have no exact amount, and most of those missing figures sit in China. Current funding in smart devices, wearables and Asia-Pacific is therefore understated automatically.

There is another distortion in the previous-period base. Vetr recorded a $21 million financing from Pale Horse Capital. Vetr's own announcement identifies founder Andrew Hamilton as both the founder of Vetr and the source of the Pale Horse Capital backing, making the transaction quite different from a conventional outside VC round.

Remove that $21 million transaction and previous disclosed capital falls from $98.38 million to around $77.38 million. The current-period decline then becomes roughly 14.4%.

Capital conditions still look weaker. Deal count fell, the market-wide median round dropped and monthly funding thinned out considerably. The 32.6% headline just makes the deterioration look more precisely measured than it really is.

Is Pet Tech turning into a winner-takes-most funding market?

Pet Tech funding has become much more concentrated: three rounds now absorb 76.2% of all precisely disclosed capital.

Digitail raised $23 million, Lupa raised $20 million and Traini raised $7.5 million. Together, those three financings account for just over $50 million in a market where only $66.27 million is precisely disclosed.

A year earlier, the top three rounds represented 55.3% of capital. The shift is unusually strong because neither period contains a $50 million-plus megaround. Concentration is building through several $7 million to $23 million rounds instead.

The average round actually edged up from $5.47 million to $5.52 million while the median fell by 33.6%. A few large financings are keeping the average high while the middle of the market gets thinner.

This is one of the clearest weaknesses in Pet Tech funding right now. The sector can still finance startups and still write $20 million checks, but increasingly those two things happen at opposite ends of the market.

Are more new Pet Tech startups getting funded now?

Pet Tech is creating more first-time funded startups today even as the total number of deals slips.

We found nine first financings in the latest period, versus six a year earlier. That is a 50% increase in absolute terms, while the first-financing share of all deals rose by 21.4 percentage points.

The companies entering the funded market also come from several directions. Hoomanely raised $1.8 million around sensor-based preventive health. Wonderdog raised $5 million for a canine-health platform built around testing and longitudinal data. Travv entered with veterinary diagnostic software, while PettiChat and several Chinese companies are building connected devices and AI-enabled pet-health products.

The startup pipeline itself looks alive. The recent Pet Tech slowdown is coming from fewer repeat rounds and a thinner middle of the funding market rather than investors walking away from new companies.

Are Pet Tech investors backing newcomers or doubling down on existing winners?

Pet Tech investors are opening more doors to newcomers, then putting most of the serious money into companies they already know.

First financings account for more than half of current deals but only 19.3% of precisely disclosed capital. Follow-ons receive the remaining 80.7%.

Ticket sizes show the same split. The median known first financing is $1.69 million, while the median follow-on is $4.43 million. Lupa, Digitail and Traini all sit in that repeat-funded group.

Interestingly, the median ticket increased within both groups. The typical first financing rose from $1.22 million to $1.69 million, while the typical follow-on increased from $3.72 million to $4.43 million. The overall market median still fell because many more deals now come from the smaller first-financing cohort.

New entrants vs existing companies	Latest 12M	Previous 12M
First financings	9	6
First-financing share	52.9%	31.6%
Disclosed first-financing capital	$12.78M	$26.73M
First-financing share of capital	19.3%	27.2%
Median known first financing	$1.69M	$1.22M
Follow-on financings	8	13
Follow-on share of capital	80.7%	72.8%
Median known follow-on	$4.43M	$3.72M

Is Pet Tech capital getting harder to find between the big rounds?

Pet Tech capital is noticeably patchier now even though deals still happen at roughly the same monthly rhythm.

The median month still contains one deal, exactly as it did a year earlier, and the busiest month still contains three. Deal flow has therefore remained fairly regular.

The amount of money available in a normal month looks much weaker. Median monthly disclosed funding fell from $3.92 million to $1.65 million, a drop of about 58%. Average monthly disclosed capital also fell from $8.20 million to $5.52 million.

That helps explain why the market feels weaker despite still producing regular announcements. Most months continue to produce activity; fewer months produce meaningful amounts of capital.

Monthly Pet Tech funding metric	Latest 12M	Previous 12M
Average deals per month	1.42	1.58
Median deals per month	1.0	1.0
Zero-deal months	2	1
Highest monthly deal count	3	3
Average disclosed capital per month	$5.52M	$8.20M
Median disclosed capital per month	$1.65M	$3.92M
Highest disclosed capital in one month	$24.68M	$41.0M

Which parts of Pet Tech are actually gaining momentum?

Pet health wearables have the cleanest funding momentum right now, while smart devices are getting more deals and tele-vet has disappeared from the current financing mix.

Wearables increased from two deals to three. Precisely disclosed funding rose from $1.38 million to almost $8 million, helped by Traini's $7.5 million financing, while SATELLAI and Moggie added further activity.

Smart Pet Devices went from one financing to three. We only know the exact size of one current deal, however, because two Chinese rounds were reported simply as "tens of millions of RMB". Their low disclosed capital total therefore tells us very little about actual investor spending.

Connected Pet Feeders also appeared through Hoomanely's $1.8 million financing. TechCrunch reported that the company had already spent 18 months beta-testing its system across more than 80 dogs and collected around five million data points before raising.

Tele Vet Platforms moved the other way. The previous period included Airvet's $11 million round, Otis's $2.3 million financing and Vetr's unusual $21 million transaction. We found no qualifying tele-vet financing in the current period.

That does not mean tele-vet activity itself stopped. Airvet continued expanding operationally during 2026, launching its service in Brazil, Ireland and Germany. Money has simply been flowing elsewhere during this funding window.

Is veterinary AI software carrying Pet Tech funding right now?

Veterinary AI software is attracting the biggest current checks, and recent operating data suggest investors are following real adoption rather than a short-lived demo cycle.

Lupa raised $20 million to expand its AI agents, enter more international markets and create a Veterinary AI Lab. The company said revenue had grown 50-fold since its previous round and that clinics were saving about an hour of veterinarian time per day after rollout.

Digitail's $23 million Series B shows the same pattern at a larger operating scale. The company said its customer base had more than doubled over the previous 12 months and now covered around 10,000 veterinarians and three million pet parents. The new money is going into product development, AI capabilities and global expansion.

A useful current cross-check comes from HappyDoc. The veterinary AI-scribe company said in July 2026 that it had processed more than two million pet visits. HappyDoc raised only $2.2 million in the earlier comparison period, yet its subsequent usage gives us another indication that veterinary AI products are moving beyond initial trials.

Pet Care Apps actually recorded fewer deals overall, falling from 13 to 10. What changed was the size and maturity of the winners. The strongest veterinary-software financings now tend to be attached to products already used inside real clinic workflows.

Is Pet Tech funding shifting from North America to China?

Pet Tech deal activity has shifted sharply toward China, although incomplete round-size disclosure makes the capital comparison much harder.

China went from three of 19 deals to seven of 17. Its share of all financings jumped from 15.8% to 41.2%, which is the largest geographic change we found.

The Chinese activity is spread across smart devices, wearables and veterinary software. SATELLAI returned to market, while new financings appeared around AI-connected pet devices, pet-health platforms, smart diagnostic hardware and other connected products.

North America moved the other way. Deal count fell from nine to six, while precisely disclosed capital dropped from roughly $84.35 million to $40.6 million.

Five of the eight current Asia-Pacific financings have no precise disclosed amount, so capital-share figures heavily understate the region. Deal count gives us the cleaner signal here: China has become a much bigger part of Pet Tech fundraising activity.

Europe provides a useful contrast. Its deal count fell from four to three, yet its disclosed capital share rose sharply because Lupa alone raised $20 million. Geography is changing through both company count and check size, depending on the region.

Are Pet Tech investors taking more risk or playing it safer now?

Pet Tech investors are taking more bets on young companies while reserving larger checks for businesses with clearer commercial proof.

Median company age at financing fell from three years to two years. Among Seed rounds, the median company age dropped from 2.5 years to one year. That fits with the increase in first financings and the larger presence of young startups in the current cohort.

The overall stage mix changed less dramatically than those age figures suggest. Early-stage deals still represent 70.6% of the market, compared with 73.7% previously.

The difference appears inside that mix. We see many small, young-company financings alongside unusually large checks for a few Series A and Series B companies. Lupa's $20 million Series A and Digitail's $23 million Series B sit at one end; early preventive-health, AI and connected-device startups sit at the other.

Pet Tech has developed a barbell shape. Investors are still willing to take early bets, while larger commitments increasingly come after a company has moved beyond the earliest validation stage.

Are fewer investors controlling Pet Tech deals now?

Pet Tech money is concentrated by company rather than by lead investor.

We identified 17 distinct disclosed names in the current lead-investor field, compared with 16 previously, despite fewer total deals. No disclosed lead appears more than once within either 12-month period.

The available evidence therefore does not show a small club of investors repeatedly controlling Pet Tech financings. Company concentration is much stronger than investor concentration.

Strategic investment is even harder to establish. Several rounds leave strategic participation undisclosed, while some announcements mention industrial involvement without identifying enough detail to classify it properly.

For now, the public evidence is too incomplete to say that corporate investors are taking over Pet Tech.

Do Pet Tech startups need more proof to raise today?

The biggest Pet Tech rounds currently come with much stronger proof than a product story alone.

Lupa entered its $20 million Series A with 50-fold revenue growth since its previous round, multi-year customer agreements and reported time savings inside clinics. Digitail entered its $23 million Series B after more than doubling its customer base.

Even much earlier companies are showing more than a prototype. Hoomanely had already gathered millions of behavioral datapoints before its $1.8 million financing and was preparing formal veterinary studies to measure sensitivity, specificity and false-positive rates. Travv's $1.6 million Seed is funding product expansion, hospital onboarding and further development of its veterinary-radiology workflow tools.

The data do not let us prove that every founder now has to wait longer before raising. Only two follow-ons in each comparison period have clean enough prior-round dates to calculate funding velocity, which is far too small a sample for a serious market conclusion.

What we can see much more clearly is the quality of evidence attached to the larger checks. Revenue growth, clinic usage, customer expansion, longitudinal data and real deployment show up repeatedly around companies that attract serious capital.

What are Pet Tech companies raising money to do now?

Pet Tech funding is increasingly paying for AI product expansion, clinic rollout and international growth at the top end of the market.

Lupa is using its Series A to expand AI agents, grow internationally and build its Veterinary AI Lab. Digitail is investing in product development, broader AI capabilities and global operations. Travv's Seed is going toward product expansion and onboarding more veterinary hospitals.

The pattern also appears outside North America. VETSTOR's investors said its financing would support new AI features, marketing and preparation for expansion into additional European markets.

Smaller companies remain closer to validation. Hoomanely is still running veterinary studies and developing additional sensing products. That puts companies at very different points in the Pet Tech lifecycle, which fits today's barbell-shaped funding market.

At the upper end, though, the pattern is pretty consistent. The largest checks are financing companies that already have a product to expand, customers to serve and a clear next market to enter.

What really changed over the last 12 months?

The latest Pet Tech funding market is producing more new funded companies while concentrating far more capital into a small group of established winners.

Rank	What changed	What it tells us
1	Capital became much more concentrated	The top three rounds now absorb 76.2% of precisely disclosed funding, compared with 55.3% previously.
2	More startups entered the funded ecosystem	First financings rose from six to nine even while total deal count fell.
3	Existing companies captured most of the serious money	Follow-ons received 80.7% of disclosed current capital.
4	Veterinary AI, connected health and China gained attention	Large veterinary-software rounds, stronger wearable activity and a sharp increase in Chinese deal count changed the market mix.
5	Pet Tech became more barbell-shaped	Young companies are still getting funded, while a handful of proven Series A and B businesses receive very large checks.
6	Bigger checks increasingly come with commercial or technical proof	Revenue growth, clinic adoption, customer expansion and validation data show up repeatedly around the strongest current rounds.
7	"Pet Tech funding fell 33%" is too simplistic	Disclosed capital did fall sharply, but weaker current disclosure and the unusual Vetr comparison round make the underlying decline less dramatic than the headline.

Overall, Pet Tech looks different more than it looks uniformly stronger or weaker. New-company formation improved, which is healthy. Capital depth, monthly availability and funding concentration worsened. The companies doing best right now tend to sit in veterinary AI, connected health or data-rich preventive care, and the larger checks are increasingly attached to evidence that the product already works in the real world.